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The effects of large coronary vesseldilation on responses
to immersion of a hand and forearm in ice water for 1
minute (that is, the cold pressor test) were calculated for
17 patients. Regional coronary blood ftowand aortic and
left ventricular pressures were continuously measured
before and during two cold pressor tests, each performed
before and after administration of sublingual (0.4 mg)
or low dose intracoronary (0.01 mg) nitroglycerin. Dur-
ing the initial cold pressor test, heart rate and coronary
pressures increased in all patients; total and regional
coronary resistance usually increased in patients with
severe coronary artery disease and usually decreased in
Recently, there has been renewed interest in the cardiovas-
cular responses to various types of cold stimuli. In partic-
ular, immersion of a hand in ice water for 1 to 2 minutes,
which is commonly referred to as the cold pressor test, has
been evaluated extensively (1-17). During the cold pressor
test, differences in coronary blood flow responses have been
recognized in comparing patients with and those without
severe coronary artery disease (1,2,5). During the cold pres-
sor test in patients without variant angina and with normal
coronary angiograms, total and regional coronary blood flow
usually increases. Coronary resistance, calculated as the
quotient of mean aortic pressure and coronary blood flow,
is unchanged or slightly decreased. In contrast, in patients
without variant angina and with severe coronary disease,
total and regional coronary blood flow changes are variable,
but coronary resistance usually increases during the cold
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patients with a normal coronary angiogram. Sublingual
nitroglycerin induced important systemic effects, but
intracoronary nitroglycerin did not; both induced dila-
tion of coronary arteries viewed angiographically. Re-
gardless of the route of nitroglycerin administration,
coronary hemodynamic responses were directionally
similar during the repeat cold pressor test compared
with the initial one. These data support the concept that
changes in tone of the large coronary arteries are not
important in producing the cardiac responses observed
during the cold pressor test.
(J Am Coli CardioI1985;5:1319-25)
pressor test. Accompanying these different coronary flow
responses, clinical, electrocardiographic and metabolic evi-
dence for transient myocardial ischemia has sometimes been
observed in patients with severe coronary artery disease.
Additionally, some investigators (11-16) using noninvasive
tests to evaluate left ventricular perfusion and wall motion
have also found impaired perfusion and new wall motion
abnormalities during the cold pressor test in patients with
coronary artery disease.
The cold pressor test usually induces minimal diffuse
reduction in coronary conductance vessel diameter of both
angiographically normal and abnormal coronary segments
in patients without variant angina (3,4). This large vessel
coronary constriction may be responsible for increased coro-
nary resistance in patients with coronary disease. A further
increase in the resistance to flow across coronary stenoses
may also lead to impaired coronary flow responses and to
an increase in coronary resistance. The cold pressor test also
occasionally induces more dramatic changes in epicardial
coronary artery size (for example, coronary artery spasm)
(4). The coronary microcirculation is another possible site
of action leading to differential coronary blood flow in pa-
tients with and those without severe coronary artery disease.
These vessels are too small to visualize angiographically
and are believed to control coronary vascular resistance.
The objective of this study was to evaluate further the
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mechanism of the cold pressor test responsible for differ-
ential coronary blood flow responses in patients with and
those without severe coronary artery disease. The cold pres-
sor test was performed before and after administration of
nitroglycerin. We hypothesized that if the major reason for
differential coronary hemodynamic responses in these pa-
tients was constriction of large, epicardial conductance ves-
sels viewed angiographically, nitroglycerin should abolish
these different coronary blood flow responses.
Methods
Patient selection. We studied 17 men (average age 57
years) undergoing cardiac catheterization to define further
the basis for their chest pain. Patients were selected to in-
clude those with predominantly exertional chest pain and
exclude those with symptoms (chest pain at rest) or ST
segment elevation suggestive of variant angina. Patients
with other forms of heart disease and recent myocardial
infarction were excluded. In 13 patients (Patients I to 13),
the electrocardiographic response to stress testing was ab-
normal, as electrocardiographic evidence for transient myo-
cardial ischemia (I mm or greater ST segment depression)
associated with chest pain was evoked. In the remaining
four patients (Patients 14 to 17), no electrocardiographic
changes were noted during stress testing. Fourteen patients
were taking propranolol at the time of the study.
Cardiac catheterization. Patients were in a fasting
postabsorptive state without premedication during cardiac
catheterization. Treatment with propranolol was not inter-
rupted before catheterization. No other alpha- or beta-ad-
renergic agents or calcium antagonists were taken by these
patients. Nitrates were omitted for at least 6 hours before
the study. A Sones catheter was advanced from the right
brachial artery to the left ventricle. Pressure recordings (Sta-
tham P23Db transducer) were made as the catheter was
withdrawn to the aorta. Mean aortic pressure was obtained
by electronic filtration. A multithermistor catheter was ad-
vanced from the right antecubital vein and positioned in the
coronary venous system (2,18-20). The distal external
thermistor was advanced to the great cardiac vein. The prox-
imal external thermistor was positioned in the sinus between
the ostium and termination of the middle cardiac veins. In
Patients 4 and 8, a stable signal from the proximal external
thermistor (coronary sinus temperature signal) could not be
obtained, and these values were omitted. No evidence for
right atrial-coronary sinus blood admixture was observed in
the other 15 patients. Standard electrocardiographic limb
leads and precordial lead V5 were recorded during all pe-
riods. Electrocardiographic leads showing the greatest mag-
nitude of ST segment shift during previous stress-induced
angina or leads I, II and V5 were continuously monitored.
Control period. A set of left and right coronary cine-
angiograms in multiple projections was filmed and recorded
on video disc. At least 5 minutes after a cineangiogram and
after any electrocardiographic or pressure changes related
to contrast injection had returned to the levels measured
before angiography (± 10%), a control electrocardiogram
was recorded. A 30 second recording was made at paper
speeds of 10 and 25 mmls and included signals of left
ventricular and aortic pressure and indicator, coronary sinus
and great cardiac vein temperatures.
While the aforementioned signals were recorded contin-
uously (10 mmls), the patient's left hand and lower forearm
were immersed in ice water. After 60 seconds, recordings
were stopped and the patient was questioned about the pres-
ence or absence of chest or hand pain, and his hand was
removed from the ice water.
Nitroglycerin period. In Patients I to 9 (group I) and
Patients 14 to 17 (group 3), 0.4 mg of sublingual nitro-
glycerin was administered at least 5 minutes after the control
period cold pressor test. Five to 8 minutes after adminis-
tration of nitroglycerin and observance of a "nitrate effect"
on the blood pressure, a 30 second recording of heart rate
and left ventricular pressure was made to confirm stability
of these values (± 5%). Then nitroglycerin period record-
ings of aortic and left ventricular pressures and indicator,
coronary sinus and great cardiac vein temperatures were
initiated.
In Patients 10 to 13 (group 2), nitroglycerin was ad-
ministered directly into the left and, if appropriate, also the
right coronary artery (10 JJ.g in each). As expected, in these
patients, no important change in aortic or left ventricular
pressures occurred (± 5%), and nitroglycerin period re-
cordings of aortic and left ventricular pressures and indi-
cator, coronary sinus and great cardiac vein temperatures
were begun 2 minutes after intracoronary nitroglycerin
administration.
While signals were recorded continuously, the patient's
left hand and lower forearm were again immersed in ice
water. After 60 seconds, recordings were stopped; the pa-
tient was again questioned about the presence or absence
of chest and hand discomfort and his hand was removed
from the ice water.
Coronary angiography was repeated using views similar
to those obtained previously. The Sones catheter was then
advanced to the left ventricle and ventriculography was per-
formed. In the patients in whom only intracoronary nitro-
glycerin had been administered, sublingual nitroglycerin was
administered before ventriculography, No patient had mitral
insufficiency.
Hemodynamic measurements and calculations. Tem-
peratures of coronary sinus and great cardiac vein blood and
indicator were continuously recorded as mentioned. Coro-
nary sinus and great cardiac vein flows were calculated.
Phasic and mean aortic pressures, left ventricular end-dia-
stolic pressure and coronary sinus and great cardiac vein
flow values obtained during the 15 second interval before
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the cold pressor test were averaged and taken as baseline
data. Between 45 and 60 seconds after the cold pressor
test began, left ventricular pressure, phasic and mean aortic
pressures, cotonary sinus and great cardiac vein flows, heart
rate and ST segment shifts were again averaged.
Coronary sinus }low was used as an index of total left
ventricular blood flo w. Great cardiac vein flow was used to
represent flow from the anterior left ventricular region . By
subtracting great cardiac vein flow from coronary sinus flow,
we obtained an index of blood flow from the remaining left
ventricular regions. For simplicity, this region was arbi-
trarily referted to as the inferior left ventricular region (2, 19).
Coronary resistance was calculated as the quotient of mean
aortic pressure and mean coronary blood flow.
Coronary and left ventricular angiographic measure-
ments and calculations. The degree of reduction in coro-
nary artery diameter was evaluated with quant itative angie-
graphic techn iques as described elsewhere (3). Coronary
stenoses were measured at their minimal diameter. Angie-
grams obtained after nitroglycerin admini stration were sub-
jectively evaluated and compared with angiograms obtained
before nitroglycerin was given to evaluate the presence or
absence of nitroglycerin-induced coronary dilation. The area
ejection fraction Wascalculated from the left ventriculogram
obtained after nitroglycerin was administered. Regional wall
motion was subjectively evaluated as normal , hypokinetic
or akinetic .
Statistical analysis. Mean values ± I standard devia-
tion were determined before and after nitroglycerin admin-
istration and before and during cold pressor testing. Paired
and unpaired t tests were used to compare coronary, sys-
temic and left ventricular hemodynamic data before and after
nitroglycerin administration and before and during cold
stimulation. A probability (p) value of less than 0.05 was
considered statistically significant.
Results
Table I summarizes the clinical findings and results of
coronary and left ventricular angiography .
Clinical and electrocardiographic findings. All pa-
tients reported pain in the left .hand and forearm immersed
in ice water both before and after nitroglycerin administra-
tion . During cold pressor testing , no patient reported chest
pain or other symptoms, and no patient had ST segment
shifts suggesting ischem ia either before or after nitroglycerin
administrat ion. No complications occurred.
Regional coronary angiographic findings. Patients
I to 13 (groups 1 and 2) had severe coronary artery disease .
Of the 26 possible left ventricular regions (anterior and
inferior) in this group, 24 were considered abnormally per-
fused and 2 were normally perfused . Patients 14 to 17 (group
3) had normal coronary angiograms; thus , both anterior and
Table 1. Summary of Pertinent Clinical and Coronary and Left Ventricular Angiographic Findings in 17 Patients
Potential
Coronary Angiogram Regional
Age Propranolol
(% diameter reduction) Perfusion Left Ventricular Angiogram
Case (yr) (mg/day) LAD LCx RCA Ant Inf EF (%) Wall Motion
Group I (coronary stenosis; sublingual nitroglycerin)
I 57 240 100 100 10 Abn Abn 39 AnI hypokinesia
2 58 80 90 100 100 Abn Abn 47 lnf akinesia
3 68 160 80 0 40 Abn Nl 60 Ant hypokinesia
4 54 0 80 0 0 Abn NI 56 NI
5 54 0 50 50 100 Abn Abn 45 lnf hypokinesia
6 60 160 80 0 0 Abn NI 65 NI
7 60 40 60 60 50 Abn Abn 65 NI
8 62 80 70 80 60 Abn Abn 61 NI
9 58 160 60 50 90 Abn Abn 62 lnf hypokinesia
Group 2 (coronary stenosis; intracoronary nitroglycerin)
10 66 0 80 50 60 Abn Abn 66 NI
II 60 120 70 60 60 Abn Abn 67 Nl
12 57 40 60 100 100 Abn Abn 36 lnf akinesia
13 55 160 10 70 100 NI Abn 60 lnf hypokinesia and akinesia
Group 3 (normal coronary arteries: sublingual nitroglycerin)
14 56 240 0 0 0 NI NI 60 NI
15 44 160 0 0 0 NI NI 70 NI
16 56 160 0 0 0 NI NI 60 NI
17 40 240 0 0 0 NI NI 65 NI
Abn = abnormal; Ant = anterior; EF = ejection fraction; lnf = inferior: LAD = left anterior descending coronary artery; LCx = left circumflex
coronary artery; NI = normal; RCA = right coronary artery.
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inferior left ventricular regions were considered normal in
this group.
A comparison of coronary angiograms obtained before
the control period with those obtained after the nitroglycerin
period showed dilation of both the left and right coronary
arteries in all 17 patients.
Systemic and left ventricular hemodynamic find-
ings. During cold pressor testing, heart rate (67 ± 8 to
70 ± 8 beats/min during the control period and 71 ± 9 to
74 ± 10 beats/min during the nitroglycerin period) and
mean aortic pressure (l03 ± 14 to 118 ± 16 mm Hg and
99 ± 18to 108 ± 16 mm Hg) usually increased both before
and after administration of nitroglycerin (all p < 0.05). Left
ventricular end-diastolic pressure (20 ± 5 to 23 ± 5 mm
Hg and 15 ± 5 to 18 ± 6 mm Hg), obtained after multiple
coronary angiograms, usually increased during cold pressor
testing both before and after administration of nitroglycerin
(both p < 0.05). In the patients who received sublingual
nitroglycerin (groups 1 and 3), as expected, heart rate usu-
ally increased and mean aortic and left ventricular end-
diastolic pressures consistently decreased after nitroglycerin
administration (all p < 0.05). In the four patients who
received intracoronary nitroglycerin (group 2), heart rate
and pressures did not significantly change.
Table 2 is a summary of individual coronary hemody-
namic findings, and Figure I is a summary of directional
changes in total and regional coronary vascular resistance
during the cold pressor test in individual patients. As pre-
viously reported by others and us (1,2,5-8), during the cold
pressor test total and regional coronary resistance usually
increased before nitroglycerin administration in patients with
severe coronary artery disease (groups 1 and 2) and usually
decreased in the patients with normal coronary angiograms
(group 3).
After nitroglycerin administration in patients in group I,
total and regional coronary blood flow changed variably with
slight increases or decreases frequently occurring. This led
to a variable change in regional resistance as compared with
control period values (p = NS). During the cold pressor
test in patients in group 1, total coronary resistance and
coronary resistance in abnormally perfused regions usually
continued to increase. In the two normally perfused regions,
recordings both before and after nitroglycerin administration
again showed a decrease in coronary resistance. Among the
14 abnormally perfused regions, coronary resistance in-
creased in 11 regions and decreased in 3 before nitroglycerin
administration and increased in 10 regions, was unchanged
in 1 and decreased in 3 after nitroglycerin administration.
In patients in group 2, no consistent change in total or
regional coronary flow or resistance was observed :J minutes
after intracoronary nitroglycerin administration. During the
cold pressor test, an increase in total and regional coronary
resistance remained the usual response. Among the eight
abnormally perfused regions, coronary resistance increased
in five regions, was unchanged in one and decreased in two
regions before nitroglycerin administration, and increased
in six and decreased in two regions after nitroglycerin
administration.
In patients in group 3, total and regional coronary flow
usually decreased after sublingual nitroglycerin administra-
tion. During both the control and the nitroglycerin periods,
total and regional coronary vascular resistance usually de-
creased during the cold pressor test. In the eight normally
perfused regions, coronary resistance increased in two re-
gions and decreased in six, both before and after nitroglyc-
erin administration. Thus, although the magnitude of change
often varied, directional responses in regional coronary re-
sistance during the cold pressor test were usually similar
before and after nitroglycerin administration.
Discussion
Nitroglycerin and coronary hemodynamic response
to cold pressor testing. These data confirm previous ob-
servations by several groups (l ,2,5-8,17) that both total
and regional coronary resistance in regions perfused by sten-
osed coronary arteries usually increase during the cold pres-
sor test. Coronary resistance usually decreases or is un-
changed in regions perfused by normal coronary arteries
(l ,2,5-8, 17). These coronary resistance responses, which
distinguish patients with and without severe coronary artery
disease, were not usually changed by nitroglycerin. In pa-
tients with severe coronary artery disease, the usual systemic
and coronary hemodynamic and angiographic effects of ni-
troglycerin were observed. Additionally, in patients with
severe coronary artery disease who received small doses of
intracoronary nitroglycerin, recordings disclosed no impor-
tant systemic or coronary hemodynamic effects 2 minutes
after nitroglycerin administration, but persistent coronary
angiographic effects were noted. Neither nitroglycerin-in-
duced coronary dilation nor, in some cases, decreases in
pressure and basal coronary blood flow altered the coronary
hemodynamic response to cold pressor testing.
Mechanisms of cold pressor test response. The effects
of other pharmacologic interventions during the cold pressor
test are helpful in attempting to elucidate the mechanism
responsible for different coronary hemodynamic responses
in patients with and without coronary artery disease. In three
patients with coronary artery disease, alpha-adrenergic
blockade with phentolamine abolished both the systemic
pressor response and the increase in coronary vascular re-
sistance (1). The calcium antagonist nifedipine also pre-
vents the increase in coronary vascular resistance during
cold pressor testing, but without having major effects on
systemic hemodynamics (6). Beta-adrenergic blockade with
propranolol was found to potentiate the increase in coronary
vascular resistance in some patients with coronary artery
disease (8). Alpha- and beta-blocking agents and a calcium
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Table 2. Summary of Coronary Hemodynamic Findings in 17 Patients
Left Ventricular Blood Flow (ml/min) Left Ventricular Coronary Resistance (mm Hg/rnl per min)
Total Ant Inr Total Ant Inf
NTG NTG NTG NTG NTG NTG
Case C CPT NTG CPT C CPT NTG CPT C CPT NTG CPT C CPT NTG CPT C CPT NTG CPT C CPT NTG CPT
Gro up I
I 61 70 77 77 13 15 22 23 48 55 55 54 1.39 1.43 0 .98 1.01 6.54 6.67 3.09 3. 39 1.77 1.82 1.24 1.42
2 156 166 137 156 106 119 88 106 50 47 49 50 0.81 0.90 0 .71 0.74 1.18 1.26 1.10 1.08 2.50 3.19 1.98 2.30
3 145 237 141 164 50 56 35 35 95 181 106 129 0 .62 0.44 0 .57 0 .55 1.80 1.88 2.29 2. 57 0 .62 0.44 0.57 0.55
4 - - - 85 90 75 83 - - - - - - 1.12 1.28 1.20 1.20
5 234 263 224 245 73 101 80 93 161 162 164 152 0 .33 0.40 0.36 0 .36 1.07 1.03 1.00 0 .95 0.48 0.64 0 .49 0 .53
6 218 242 225 283 154 163 138 156 64 79 87 127 0 .50 0.50 0.44 0.41 0 .70 0.83 0.72 0.74 1.69 1.71 1.15 0 .61
7 164 207 150 200 82 100 84 88 82 107 66 112 0.67 0.63 0 .73 0 .60 1.34 1.30 1.31 1.36 1.34 1.21 1.67 1.07
8 - - - 209 245 214 194 - - - - - - 0.57 0.61 0.51 0 .67
9 158 163 145 149 83 85 72 72 75 78 73 77 0 .76 0.81 0 .74 0 .87 1.45 1.55 1.49 1.81 1.60 1.69 1.47 1.69
Group 2
10 83 99 102 III · 40 30 36 26 43 63 72 85 1.20 1.19 0.98 1.01 2.50 3.28 3.33 4.31 2.33 1.87 1.39 1.32
II 154 182 160 162 43 46 49 56 III 136 III 106 0 .62 0 .64 0 .61 0.68 2.21 2.54 2.00 1.96 0.86 0.86 0.88 1.04
12 125 128 129 125 38 41 40 44 87 87 89 80 0.88 0.90 0.81 0 .96 2.89 2.80 2.63 2.73 1.26 1.32 1.18 1.50 rl0
13 199 221 173 190 87 112 85 103 112 109 88 87 0.55 0. 61 0.64 0.68 1.26 1.29 1.21 1.26 0 .98 1.24 1.25 1.49 r-0
Group 3 -e
14 193 244 108 142 42 53 39 56 151 191 69 8'6 lJ.47 0.45 0 .72 0 .61 2.14 2.08 2.00 1.55 0 .60 0 .58 1. 13 1.01 ~en
15 81 106 81 106 42 54 39 46 39 52 42 60 1.26 1.20 1.15 1.04 2.43 2.35 2.38 2.39 2.62 2.44 2.21 1.83 0
'"16 162 177 148 178 79 100 66 91 83 77 82 87 0.74 0 .71 0 .61 0 .53 1.52 1.25 1.36 1.04 1.45 1.62 1.10 1.09 ~17 86 98 67 71 72 81 46 56 14 17 21 15 1.16 1.17 1.34 1.38 1.39 1.42 1.96 1.75 7.14 6.76 4.29 6.53
-l
C = control : CPT = cold pressor test: NTG = nitroglycerin: other abbreviations as in Table I . ~0
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Figure 1. Summary of percent change
in regional coronaryresistance during
cold pressortesting. Percentchangein
regional coronary resistance before
(horizontal axis) and after (vertical
axis) nitroglycerin administration was
compared and each coronary region
was represented by I point. Corollary
hemodynamic responses to cold pres-
sortestingthatweresimilarbeforeand
after nitroglycerin are shown in the
shaded quadrants (right upper or
left lower). Those that appeared to be
altered by nitroglycerin are shown in
unshaded quadrants (left upper and
right lower). Most points lie in the
right upper or left lower quadrant
because coronary hemodynamic re-
sponses were not alteredby nitroglyc-
erin administration.II CHANGE BEFORE NITROGlVCERIN
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antagonist, medications that have greater effects on coronary
resistance than on coronary capacitance vessels, altered
coronary hemodynamics during the cold pressor test, whereas
nitroglycerin, with its predominant effect on large con-
ductance vessels, had little or no effect on coronary hemo-
dynamic responses. This evidence supports the hypothesis
originally presented by Mudge et al. (l) that coronary hemo-
dynamic responses during cold stimulation are mediated
predominantly by the responses of small distal resistance
vessels.
In patients with coronary artery disease, active vaso-
constriction of resistance vessels in response to the predom-
inantly alpha-adrenergic discharge associated with the cold
pressor test must overwhelm the metabolically mediated
vasodilation initiated by increased heart rate, preload and
afterload, A limited coronary reserve is unmasked by these
two opposing stimuli in patients with severe coronary dis-
ease whose resistance vessels are presumably already dilated
in the basal state to compensate for large vessel stenoses.
Additionally, because nitroglycerin did not alter coronary
hemodynamic responses during cold pressor testing, the
small degree of alpha-adrenergic-mediated large vessel con-
strictionof angiographically normal and diseased segments
must be of less importance than responses in the small
resistance vessels. In patients without coronary disease, there
is little hindrance in coronary blood flow in the large vessels.
They have more vasodilatory reserve in the resistance ves-
sels, and modest constriction of the large conductance ar-
teries is probably not physiologically important. Thus, coro-
nary flow can increase appropriately during the cold pressor
test.
Variability of individual responses. Although changes
in coronary vascular resistance during the cold pressor test
usually distinguish patients with from those without coro-
nary artery disease, individual responses are variable. Some
of this variability is probably related to the severity of the
underlying coronary disease because many patients have
regions perfused by normal and by mildly and severely
narrowed vessels. In patients without very severe stenoses
of all major coronary branches, regional and global coronary
hemodynamic responses differ from those in patients with
severe narrowing of all branches or in others with a normal
angiogram (2). Additionally, differences in coronary blood
flow and pressure changes during 'the cold pressor test are
small, comparing patients with or without coronary disease
or, in some instances, comparing different regions in pa-
tients with relatively localized coronary artery disease. Thus,
any inaccuracies in measuring regional or total coronary
venous blood flow would add to the scatter in the data. We
previously documented (2,18-20) our ability to reproduc-
ibly measure regional and total coronary blood flows; how-
ever, even small changes in measurement of regional flow
within our usual variability (± 5 mllmin at these flow rates)
could have important consequences relative to conclusions
concerning coronary hemodynamic responses during the cold
pressor test. The continuous pressure and flow recordings
begun immediately before and continued throughout im-
mersion of the patient's hand in ice water allowed ongoing
inspection of the flow and pressure tracings. This was cou-
pled with frequent fluoroscopic inspection of coronary ve-
nous catheter position. We hope that this method minimized
any errors intrinsic in the regional coronary venous flow
technique.
Study limitations. Several other limitations of this study
deserve comment. First, 14 patients were taking propran-
olol. Although acute beta-receptor blockade has been re-
ported (1,8) to potentiate coronary hemodynamic responses
to the cold pressor test, the effect of chronic beta-blockade
JACCVol. 5, No.6
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is less clear, Any effect of beta-blockade that was present
would have been constant before and after nitroglycerin
administration. Second, venous drainage of the right coro-
nary artery varies and is not always represented by sampling
of coronary sinus flow. A small portion of the venous drain-
age of the left anterior descending coronary artery branches
can also drain into the coronary sinus distal to the site used
to sample the great cardiac vein. In addition, it is likely that
a small portion of the flow from the intermediate and obtuse
marginal branches of the left circumflex coronary artery
drain into the great cardiac vein. Therefore, the reported
measurements of regional venous flow should be considered
as only relative estimates.
Clinical implications. Responses of the coronary cir-
culation during cold stimulation have received considerable
attention over the past several years. Previously, some in-
vestigators equated the increases in coronary resistance dur-
ing cold stimulation in patients with coronary artery disease
as a response similar to coronary artery spasm. Considering
the angiographic and hemodynamic studies now available
on these two different groups of patients, no further con-
fusion should occur.
In conclusion, the coronary hemodynamic responses dur-
ing cold pressor testing are unaltered by sublingual or intra-
coronary nitroglycerin administration. The increase in coro-
nary vascular resistance usually seen in patients with coronary
artery disease contrasts with a small decrease or no change
in coronary resistance usually seen in patients with a normal
angiogram. This differential response is most likely to be
secondary to differences in responses of the coronary mi-
crocirculation in patients with and without coronary artery
disease.
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